帕金森病(颤拘病)中医临床诊疗专家共识

2021-11-26 广州中医药大学第二附属医院 中医杂志

帕金森病是一种中脑黑质纹状体通路障碍的缓慢进展变性疾病,多见于中老年人,以运动迟缓、静止性震颤和肌强直为主要临床特征。

中文标题:

帕金森病(颤拘病)中医临床诊疗专家共识

发布日期:

2021-11-26

简要介绍:

帕金森病是一种中脑黑质纹状体通路障碍的缓慢进展变性疾病,多见于中老年人,以运动迟缓、静止性震颤和肌强直为主要临床特征[1]。帕金森病目前仍以药物治疗为主,但迄今尚无根治药物。复方左旋多巴类仍是控制运动症状的最有效西药,但几乎所有病例均需终身服药以控制症状,很多患者常因不能耐受药物副作用被迫停药;而脑深部电刺激术虽可明显改善症状,但仍不能根治,也不能控制疾病进展[2]26。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=_帕金森病(颤拘病)中医临床诊疗专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=80cc01c0022e8081, title=帕金森病(颤拘病)中医临床诊疗专家共识, enTitle=, guiderFrom=中医杂志, authorId=0, author=, summary=帕金森病是一种中脑黑质纹状体通路障碍的缓慢进展变性疾病,多见于中老年人,以运动迟缓、静止性震颤和肌强直为主要临床特征。, cover=https://img.medsci.cn/20211130/1638243166211_5579292.png, journalId=0, articlesId=null, associationId=2176, associationName=广州中医药大学第二附属医院, associationIntro=广州中医药大学第二附属医院, copyright=0, guiderPublishedTime=Fri Nov 26 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">帕金森病是一种中脑黑质纹状体通路障碍的缓慢进展变性疾病,多见于中老年人,以运动迟缓、静止性震颤和肌强直为主要临床特征</span><sup style="color: #333333;">[1]</sup><span style="color: #333333;">。帕金森病目前仍以药物治疗为主,但迄今尚无根治药物。复方左旋多巴类仍是控制运动症状的最有效西药,但几乎所有病例均需终身服药以控制症状,很多患者常因不能耐受药物副作用被迫停药;而脑深部电刺激术虽可明显改善症状,但仍不能根治,也不能控制疾病进展</span><sup style="color: #333333;">[2]26</sup><span style="color: #333333;">。&nbsp;</span></p>, tagList=[TagDto(tagId=337, tagName=帕金森病), TagDto(tagId=5308, tagName=神经变性疾病)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=37, categoryName=中医科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=337, guiderKeyword=帕金森病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4932, appHits=187, showAppHits=0, pcHits=708, showPcHits=4744, likes=3, shares=23, comments=4, approvalStatus=1, publishedTime=Tue Nov 30 12:01:27 CST 2021, publishedTimeString=2021-11-26, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Nov 30 11:37:05 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 14:47:33 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=_帕金森病(颤拘病)中医临床诊疗专家共识.pdf)])
_帕金森病(颤拘病)中医临床诊疗专家共识.pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1239690, encodeId=f5e81239690bf, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db65420676, createdName=臣服, createdTime=Fri Aug 19 11:12:17 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206025, encodeId=b951120602522, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70855721040, createdName=ms6000000299174371, createdTime=Sat Mar 26 06:10:54 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082423, encodeId=4cf9108242371, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:54:29 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075826, encodeId=5c8810e582606, content=攒了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29e04020890, createdName=马金红, createdTime=Wed Dec 01 11:43:32 CST 2021, time=2021-12-01, status=1, ipAttribution=)]
    2022-08-19 臣服

    666

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1239690, encodeId=f5e81239690bf, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db65420676, createdName=臣服, createdTime=Fri Aug 19 11:12:17 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206025, encodeId=b951120602522, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70855721040, createdName=ms6000000299174371, createdTime=Sat Mar 26 06:10:54 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082423, encodeId=4cf9108242371, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:54:29 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075826, encodeId=5c8810e582606, content=攒了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29e04020890, createdName=马金红, createdTime=Wed Dec 01 11:43:32 CST 2021, time=2021-12-01, status=1, ipAttribution=)]
    2022-03-26 ms6000000299174371

    好资料

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1239690, encodeId=f5e81239690bf, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db65420676, createdName=臣服, createdTime=Fri Aug 19 11:12:17 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206025, encodeId=b951120602522, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70855721040, createdName=ms6000000299174371, createdTime=Sat Mar 26 06:10:54 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082423, encodeId=4cf9108242371, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:54:29 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075826, encodeId=5c8810e582606, content=攒了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29e04020890, createdName=马金红, createdTime=Wed Dec 01 11:43:32 CST 2021, time=2021-12-01, status=1, ipAttribution=)]
    2021-12-21 龙珠

    学习好资料!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1239690, encodeId=f5e81239690bf, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db65420676, createdName=臣服, createdTime=Fri Aug 19 11:12:17 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206025, encodeId=b951120602522, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70855721040, createdName=ms6000000299174371, createdTime=Sat Mar 26 06:10:54 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082423, encodeId=4cf9108242371, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:54:29 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075826, encodeId=5c8810e582606, content=攒了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29e04020890, createdName=马金红, createdTime=Wed Dec 01 11:43:32 CST 2021, time=2021-12-01, status=1, ipAttribution=)]
    2021-12-01 马金红

    攒了

    0

拓展阅读

2015 ICS指南:帕金森病和其他步态障碍性疾病膀胱功能障碍的管理

国际尿控协会(ICS,International Continence Society) · 2015-03-25

中国帕金森病的诊断标准(2016版)

中华医学会神经病学分会帕金森病及运动障碍学组 · 2016-07-11

2016 中国帕金森病及运动障碍疾病临床大数据库建设专家共识

中华医学会神经病学分会帕金森病及运动障碍学组 · 2016-07-30

帕金森病脑深部电刺激疗法术后程控中国专家共识

中华医学会神经外科学分会 · 2016-12-30

2016中国帕金森病诊断标准解读

暂未更新 · 2017-04-06

帕金森病康复中国专家共识

中华医学会神经病学分会神经康复学组 · 2018-04-15